GH - Guardant shares on hold for trading ahead of AdCom meeting on cancer test
2024-05-23 08:39:07 ET
More on Guardant Health
- Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript
- Guardant Health: Shield Launch Could Drive Multiple Expansion
- Guardant Health slips as FDA comments on cancer screening test
- Guardant Health Non-GAAP EPS of -$0.46 beats by $0.27, revenue of $168.5M beats by $18.43M
- Seeking Alpha’s Quant Rating on Guardant Health